Thyrocare Technologies Limited has informed the Exchange about Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their Immediate Relatives.
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Thyrocare Technologies has submitted its Code of Conduct to the Exchange, which lays down rules to regulate, monitor, and report trading in the company's shares by designated persons (such as directors, key managerial personnel, and employees) and their immediate relatives. This code is a mandatory requirement under SEBI's Prohibition of Insider Trading Regulations. The filing is a routine compliance disclosure and does not involve any new policy change, financial numbers, or business developments. It simply confirms that the company has the required internal trading guidelines in place to prevent insider trading.
This is a routine regulatory filing with no direct impact on shareholders or stock price. It reassures investors that the company has proper insider trading controls in place.